The Mulligan Law Firm is Investigating Injury Claims: Acne Drug Accutane® has been linked to Inflammatory Bowel Disease, and Other Serious Side-Effects

The Mulligan Law Firm is currently investigating injury claims involving Accutane’s possible role in inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis.

Someone who has been seriously injured after taking Accutane should consult with a legal professional immediately. The Mulligan Law Firm has experienced lawyers standing by to help them.

Dallas, TX September 30, 2009 — The Mulligan Law Firm is a national law firm located in Dallas, Texas, providing information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995.

The Mulligan Law Firm is currently investigating injury claims involving Accutane’s possible role in inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis. Someone who has been seriously injured after taking Accutane should consult with a legal professional immediately. The Mulligan Firm has experienced lawyers standing by to help them. Contact Eric Gruenwald, Lawyer/Attorney or Attorney/Lawyer at 866-529-0001, EXT 245.

Along with other side-effects, Accutane® is suspected as a possible cause of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Even after treatment with Accutane has been discontinued, these serious digestive disorders can persist. While Crohn’s disease has no known cure, ulcerative colitis can often be cured by surgery, but surgical removal of the large intestine and/or colon are as permanent and life-changing as the disease itself.

In the United States, several jury trials have awarded at least $33 million dollars to patients as compensation for injuries attributed to Accutane use. The total number of claims against Roche Holding Ltd., the maker of Accutane, is believed to exceed 5,000, with at least 425 injury cases pending.

After the outcome of these jury trials, Roche Pharmaceuticals notified the FDA that they were immediately discontinuing the distribution and manufacture of Accutane in the United States. One of the reasons given by Roche for the decision: the high cost of personal-injury lawsuits.

The Mulligan Law Firm takes all cases on a contingency-fee basis, which means the prospective client does not pay for our services unless an award or compensation is received.

About Accutane
Accutane (also known as Isotretinoin) has been used by about 13 million people since it first became available in 1982. Its primary use is for the treatment of severe nodular acne, in patients who fail to respond to other acne treatments such as antibiotics.

Accutane works by reducing the amount of oil released by oil-glands in the skin, and helps the skin to renew itself. Accutane was Roche’s second-biggest selling drug until the patent expired in 2003, at which time generic versions could be sold.

The names of these generic versions of Isotretinoin/Acutane are Amnesteem®, Claravis™, Clarus™, Decutan, Isotane, Izotek, Oratane®, Sotret®, Isotrex®, and Isotrexin®.

Leave a Reply